Drugs / Leucostim
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02762799 | Jul → Nov 2016 | leukocyte disorder | Biocad | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT03343145 | Jan 2017 → Jan 2019 | breast cancer | Dong-A ST Co., Ltd. | Completed | No outcome recorded |
Press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2009-11-11 | Dong-A ST Co., Ltd. | Dong-A Pharm Exports Leucostim, a Biologic, to Turkey donga-st.com ↗ |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Leucostim | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03343145 ↗ |
| Route | Subcutaneous | “single subcutaneous injection Leucostim®” NCT02762799 ↗ |